Evidence Hub

Extracorporeal near-infrared-activated antimicrobial photodynamic therapy for pneumonia using an ICG-polymer formulation

Fiuza LG, Almeida de Lima I, Alves F, Barreto Requena M, Guerra VG, Pires L, Kurachi C, Mayumi Inada N et al.

Biophotonics discovery, 2026

Abstract

Significance: Pneumonia remains a global health challenge, exacerbated by antimicrobial resistance, which limits the effectiveness of conventional treatments. Antimicrobial photodynamic therapy (aPDT) has emerged as a promising alternative for lower respiratory infections; however, its in vivo performance is hindered by lung surfactant, which traps photosensitizers and reduces their ability to reach bacterial targets.

Aim: To address this limitation, recent studies demonstrated that combining indocyanine green (ICG) with the polymer Gantrez AN-139 enhances photodynamic activity even in the presence of lung surfactants.

Approach: We assessed the therapeutic potential of this formulation in a murine pneumonia model using pulmonary delivery followed by 808 nm infrared irradiation.

Results: Nebulization of 200 μM ICG with 4% Gantrez AN-139 and irradiation at 120 J/cm2 yielded the best results, reducing bacterial load by up to 3 log10 and improving survival to 80%, compared with 40% in controls.

Conclusion: These findings validate the formulation and the procedure for further animal studies.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free